ArticleScientific reports2026
Formation of PVDF membranes with distinct pore morphologies interpreted through the framework of viscoelastic phase separation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The formation of polyvinylidene fluoride (PVDF) membranes by vapor-induced phase separation (VIPS) is known to depend strongly on the dissolution temperature of the casting solution, yet the mechanism linking dissolution conditions to membrane morphology has remained unclear. Here we investigate this relationship by correlating dissolution temperature, solution rheology, polymer crystallization behavior, and membrane microstructure within the theoretical framework of viscoelastic phase separation (VPS). Rheological measurements, FTIR-ATR spectroscopy of solutions and membranes, and scanning electron microscopy of the resulting membranes reveal that PVDF/DMSO solutions exhibit a distinct temperature window bounded by the minimum and critical dissolution temperatures [Formula: see text] and [Formula: see text]. Below [Formula: see text], incomplete dissolution leaves residual α-polymorph microcrystallites in solution that act as thermoreversible multichain junctions. These junctions form a transient stress-bearing network that increases solution viscoelasticity and promotes elastic phase separation (EPS). Above [Formula: see text] these junctions dissolve, reducing the viscoelastic constraint and allowing phase separation to proceed predominantly in the fluid phase separation (FPS) regime. Within the VPS framework, the Weissenberg number ($Wi$), defined as the ratio between the stress-relaxation time of the polymer-rich phase and the deformation time scale generated during phase separation, provides an experimentally accessible descriptor of this transition. A morphology regime diagram relating the initial Weissenberg number ([Formula: see text]) to the observed membrane structures shows that bicontinuous morphologies occur for [Formula: see text], whereas nodular structures form when [Formula: see text]. Remarkably, the condition [Formula: see text] lies within the dissolution-temperature window previously associated with α-polymorph prevalence, while higher dissolution temperatures favor β-phase formation due to increased chain mobility during demixing. These findings establish a mechanistic connection between dissolution temperature, transient microcrystalline junction networks, solution viscoelasticity, and membrane microstructure. More broadly, they demonstrate how viscoelastic phase-separation theory can provide a unified framework for understanding and rationally controlling membrane formation from semicrystalline polymer solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.